For LabSolutions™ LCMS A Complete Method for Analysis of 28 Bile Acids Bile acids are primarily produced through the breakdown of cholesterol in the liver. Primary bile acids can then be conjugated with taurine or glycine and/or converted into secondary bile acids by gut bacteria. Their role as digestive surfactants to promote the absorption […]
For LabSolutions™ LCMS Method package including 129 veterinary drug compounds, more than 3 times as many as Ver. 1 High-speed method with just 16.5 mins detection time Pretreatment program to improve the peak shape for polar veterinary drug compounds Data analysis is made simple with LabSolutions Insight™ Simultaneous analysis of 129 veterinary drug compounds […]
Shimadzu Corporation announces the release of the new C2MAP-2030 automatic pretreatment system for cell culture media analysis. The product automates the sample pretreatment process required prior to simultaneous analysis of culture media components in a high-performance liquid chromatograph mass spectrometer (LC-MS/MS). A successor to the C2MAP-2000, released in 2017, the C2MAP-2030 offers easier operation and […]
SHERBROOKE WELCOMES THE FIRST WATERS CENTRE OF INNOVATION IN CANADA SHERBROOKE, QC – Waters Corporation inaugurates the first ever Centre of Innovation for Mass Spectrometry in Canada here in Sherbrooke. The research will focus on applying and transferring knowledge to clinical practice and aims to improve the diagnosis of rare genetic diseases, leading to personalized patient follow-up. Several hundred people are expected […]
908 Devices, a pioneer of analytical devices for chemical and biomolecular analysis, today announced it has closed $17.5 million in a growth equity funding round. This Series E funding brings the company’s total to $70M, making 908 Devices the most well-resourced upstart in the multibillion-dollar mass spectrometry market. The round was led by Northpond Ventures, […]
Thermo Fisher and NX Prenatal to develop clinical mass spectrometry-based workflows for monitoring maternal and fetal health during pregnancy and evaluating risk of complications San Jose, Calif. – Thermo Fisher Scientific, the world leader in serving science, and NX Prenatal Inc., a recognized leader in the detection, monitoring and management of pregnancy-related complications using novel exosome-based methods, […]
– Reference library expansion for broader species identification by MALDI Biotyper (MBT) – Increased speed for high-throughput projects by multi-threading MBT HT software (RUO) – Increased microbial ID from positive blood cultures with improved Sepsityper™ kit – Easier subtyping for hospital hygiene and infection control with improved IR Biotyper – Expanded assay portfolio for novel […]
Genovis, a leader in the development of enzymatic tools and technologies, have entered into a collaboration agreement with Thermo Fisher Scientific to develop advanced end-to-end workflows for the preparation, characterization and monitoring of novel and complex biotherapeutics using liquid chromatography-mass spectrometry (LC-MS). The collaborative partnership with Thermo Fisher aims to develop advanced end-to-end methods for the […]
Thermo Fisher and Genovis to develop advanced end-to-end workflows for biotherapeutics analysis Sunnyvale, CA – Thermo Fisher Scientific, the world leader in serving science, and Genovis, a leading provider of enzyme products for biological drug development, begin a collaborative research project to develop advanced end-to-end workflows for the preparation, characterization and monitoring of novel and complex […]
LOUISVILLE, Ky. — NX Prenatal Inc. (“NX Prenatal”) today announced that it has entered into a strategic collaboration with Thermo Fisher Scientific. The collaboration is designed to expand upon integrated workflows that the companies have established to enable high volume clinical mass spec proteomic evaluation of plasma samples enriched for exosomes via the NeXosome® platform. NX Prenatal’s […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
